A phase I study of topotecan in combination with docetaxel in patients with refractory and/or advanced solid tumors
Phase of Trial: Phase I
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Topotecan (Primary) ; Docetaxel
- Indications Solid tumours
- Focus Adverse reactions
- 22 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Nov 2005 New trial record.